Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001197350-26-000009

CHIEF FINANCIAL OFFICER sold 6,001 shares at $99.90 ($599,510)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BJERKHOLT ERIC · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-11 Sale : show line 1 in the form 10b5-1 −6,001 $99.90 $599,510 36,355 D
Open-market sales · 6,001 sh · avg $99.90 · $599,510
Loading xslF345X06/form4-08122026_090835.xml…